Skip to main content

Ojjaara

NDC 81864-103 · GlaxoSmithKline LLC

Generic nameMomelotinib

Dosage formTABLET

RouteORAL

Active ingredient(s)MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE

Strength100 mg/1

Pharmacologic classBreast Cancer Resistance Protein Inhibitors [MoA], Kinase Inhibitor [EPC], Kinase Inhibitors [MoA]

Marketing categoryNDA

Packages

81864-103-30 — 30 TABLET in 1 BOTTLE (81864-103-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

81864-101 — Momelotinib, 81864-102 — Momelotinib

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels